Guiding a company through a merger or an acquisition can test a CEO’s leadership skills. Here’s how NinePoint Medical CEO, Christopher von Jako, led his former medtech company, NeuroTherm, through a deal with St. Jude Medical. When Christopher von Jako assumed the corner office at NeuroTherm in 2013, the company had gone through two other […]
NeuroTherm Inc.
Medtech M&A: Tips from the front lines
S2N recently hosted an informal gathering of emerging med tech CEOs, a sort of group therapy session for people suffering from the form of temporary insanity that makes one want to be a healthcare entrepreneur.
Allergan calls out Valeant on latest earnings report : The week in medtech M&A
St. Jude closes $200M NeuroTherm buy
Medtech titan St. Jude Medical (NYSE:STJ) officially entered the spinal pain market this week, announcing the close of its $200 million cash acquisition of NeuroTherm.
Covidien shareholder files class action lawsuit blocking company’s merger with Medtronic | The week in medtech M&A
St. Jude drops $200M on NeuroTherm for spinal pain device
Minnesota-based medtech giant St. Jude Medical (NYSE:STJ) is broaching new ground in the spinal pain market with the $200 million acquisition of NeuroTherm, maker of radiofrequency ablation therapies.
InVivo CSO steps down after less than 1 year on the job | Personnel Moves
Arthocare sells off spine product lines for $5.5 million | Acquisitions roundup
ArthroCare Corp. (NSDQ:ARTC) sold its Parallax and Contour product lines to NeuroTherm for $5.5 million.
The two lines of spine products were previously reported as discontinued operations.
Wilmington, Mass.-based NeuroTherm manufactures products used in pain management, including the first multi-lesion radiofrequency generator on the market, according to a company release.
NeuroTherm buys Smith & Nephew’s spine pain management line
NeuroTherm added another asset to its portfolio of pain management products with yet another acquisition, this time of Smith & Nephew plc’s (NYSE:SNN) interventional spine pain management line.
The deal, for an undisclosed amount, brings Smith & Nephew’s CDS discography system, SpineCath and AcuTherm catheters and a full radiofrequency product line under Wilmington, Mass.-based NeuroTherm’s umbrella. The deal also calls for NeuroTherm to distribute Smith & Nephew’s TruCath injection system. Financial terms were not disclosed.
NeuroTherm hits the acquisitions trail again
NeuroTherm Inc. added to its portfolio of pain management technologies with the acquisition of some of a European company’s needle lines.
The Wilmington, Mass.-based medical device maker paid an undisclosed amount for Dutch firm Technomed Europe’s intellectual property and manufacturing know-how "associated with certain needle product lines," according to a press release.
NeuroTherm bought Micron Catheter last summer for an undisclosed amount, adding the Palm Beach gardens, Fla.-based company’s epidural scar removal catheter to its holdings.
